tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

GB:MXCT Stock Latest News

BlackRock Ups Stake in MaxCyte to 9.75%
Company AnnouncementsBlackRock Ups Stake in MaxCyte to 9.75%
20h ago
MXCT
MaxCyte, Kamau Therapeutics enter strategic platform license agreement
PremiumThe Fly
MaxCyte, Kamau Therapeutics enter strategic platform license agreement
5d ago
MXCT
MaxCyte Partners with Kamau Therapeutics to Advance Gene Therapies
PremiumCompany Announcements
MaxCyte Partners with Kamau Therapeutics to Advance Gene Therapies
5d ago
MXCT
BlackRock Ups Stake in MaxCyte to 9.74%
PremiumCompany Announcements
BlackRock Ups Stake in MaxCyte to 9.74%
5d ago
MXCT
MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic Diseases
PremiumPress Releases
MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic Diseases
5d ago
MXCT
MaxCyte Director Executes Options, Sells Shares
PremiumCompany AnnouncementsMaxCyte Director Executes Options, Sells Shares
14d ago
MXCT
MaxCyte Announces Participation in Bioprocessing Conference
Premium
Company Announcements
MaxCyte Announces Participation in Bioprocessing Conference
14d ago
MXCT
MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference
Premium
Press Releases
MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference
16d ago
MXCT
MaxCyte management to meet with Stephens
PremiumThe Fly
MaxCyte management to meet with Stephens
18d ago
MXCT
MaxCyte Director Executes Stock Options and Sells
PremiumCompany Announcements
MaxCyte Director Executes Stock Options and Sells
23d ago
MXCT
MaxCyte reports Q2 EPS (9c), consensus (13c)
PremiumThe Fly
MaxCyte reports Q2 EPS (9c), consensus (13c)
2M ago
MXCT
MaxCyte Updates Corporate Presentation for Investor Insight
PremiumCompany Announcements
MaxCyte Updates Corporate Presentation for Investor Insight
2M ago
8K
MXCT
MXCT Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsMXCT Upcoming Earnings Report: What to Expect?
2M ago
MXCT
MaxCyte Issues New Shares, Updates Capital
Premium
Company Announcements
MaxCyte Issues New Shares, Updates Capital
2M ago
MXCT
MaxCyte Director Executes Stock Options and Sells Shares
Premium
Company Announcements
MaxCyte Director Executes Stock Options and Sells Shares
2M ago
MXCT
MaxCyte to Unveil Q2 2024 Financial Results
PremiumCompany Announcements
MaxCyte to Unveil Q2 2024 Financial Results
2M ago
MXCT
MaxCyte to Report Second Quarter 2024 Financial Results on August 6, 2024
PremiumPress Releases
MaxCyte to Report Second Quarter 2024 Financial Results on August 6, 2024
2M ago
MXCT
MaxCyte Announces Broker Name Change Post-Merger
PremiumCompany Announcements
MaxCyte Announces Broker Name Change Post-Merger
2M ago
MXCT
MaxCyte Director Executes Options and Sells Shares
PremiumCompany Announcements
MaxCyte Director Executes Options and Sells Shares
3M ago
MXCT
MaxCyte Issues New Shares, Updates Voting Rights
PremiumCompany AnnouncementsMaxCyte Issues New Shares, Updates Voting Rights
3M ago
MXCT
MaxCyte Releases Key Annual Report for 2023
Premium
Company Announcements
MaxCyte Releases Key Annual Report for 2023
3M ago
MXCT
MaxCyte Awards Stock Options and RSUs to Directors
Premium
Company Announcements
MaxCyte Awards Stock Options and RSUs to Directors
3M ago
MXCT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >